PRESS RELEASES BACK NUMBER

SEARCH
2014.12.04
【News】Issuance of new shares and convertible bonds through an international offering
2014.12.04
【News】Rakuten Securities’ report on CYBERDYNE’s financing, which differed from the facts
2014.11.18
【News】Signing ceremony for basic agreement with Koriyama – for constructing a next-generation and multi-purpose production base in Fukushima Prefecture, the center of medical device production –
2014.11.15
【News】CYBERDYNE Inc. submitted final application for market clearance from the U.S. Food and Drug Administration (“FDA”) ~ the first DeNovo submission by a Japanese company for a “novel” medical device
2014.11.12
【News】 HAL received the world-first certificates of an international safety standard as wearable robots for workers and caregivers
2014.11.10
【News】Herbert Lauterbach Award 2014 to Bergmannsheil Bochum for HAL- exoskeleton research
2014.10.22
【News】 Subsidy for “Fukushima medical / welfare device development and commercialization funding” was decided to be granted
2014.10.03
【News】Kawasaki City proposed a project that included CYBERDYNE Inc. for accelerating practical application of newly developed medical devices through deregulation ~ Conference of Members of Tokyo National Strategic Zone ~
2014.09.30
【News】CYBERDYNE Inc. launched HAL® for Task Support to enter fields of heavy work assistance devices
2014.09.22
Update【News】 Article regarding efficacy of HAL For Medical Use was published in US medical magazine “Neurology”
2014.09.12
【News】Scope of clinical study of HAL ® for Medical Use expanded to include spinal cord disease
2014.09.09
【News】Proposal for National Strategic Zone
2014.08.27
【News】CYBERDYNE’s R&D Projects Selected for Fukushima Prefecture’s “Industrial Integration of Disaster Response Robots Subsidy Program
2014.08.15
【News】Completion of the implementation stage of the physician-led clinical trial of Robot Suit HAL for Medical Use
2014.08.08
【News】Announcement of accepted bid to purchase land in International Strategic Zone in Tonomachi, Kawasaki City, Japan
2014.08.01
【News】CYBERDYNE Inc. has begun seeking approval from the U. S. Food and Drug Administration (FDA)
2014.06.19
【News】CYBERDYNE has concluded a comprehensive agreement with Kawasaki City, a member municipality of the National Strategic Zone.
2014.06.16
【News】Adopted as an eligible for “Fukushima medical / welfare device development and commercialization funding”
2014.05.22
【News】Won Special Prize for New Public Equity Issues Category in Capital Eye Awards 2013.
2014.05.20
【News】Harvard Business School Professors paid attention to and appreciated CYBERDYNE’s (a university venture’s) innovative technology and its attempt to create new market.
BACK TO TOP